港股异动 | 健世科技-B(09877)涨超8% 两款核心治疗心脏瓣膜疾病产品获新西兰注册批准

智通财经
Feb 26

智通财经APP获悉,健世科技-B(09877)涨超8%,截至发稿,涨8.49%,报9.2港元,成交额104.44万港元。

消息面上,健世科技今早发布公告称,公司的经导管主动脉瓣置换系统Ken-Valve和经血管三尖瓣置换系统LuX-ValvePlus已于近日取得新西兰药品和医疗器械安全局的注册批准,公司正积极推动两款产品于新西兰的商业化。

公告指出,得益于产品的设计优势、已开展的注册临床试验及持续进行的疗法推广工作,Ken-Valve和LuX-ValvePlus已获得了市场的广泛认可。随着两个重要产品取得新西兰药品和医疗器械安全局的注册批准,公司将加快产品组合的全球商业化进程,以进一步实现本公司长期战略目标。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10